Company Performance: SEELQ's financial health and performance metrics, such as revenue, profitability, and earnings per share, directly impact investor confidence and stock price.

Market Sentiment: General investor mood and prevailing market trends influence trading activity in SEELQ, leading to price fluctuations based on optimism or pessimism.

Industry Trends: Changes and developments within the pharmaceutical industry, including regulatory updates, technological advancements, and competitive pressures, affect SEELQ's perceived value.

Drug Pipeline: Progress in the development and approval of new drugs in SEELQ's pipeline significantly influences investor expectations and future revenue potential, impacting stock valuation.

Regulatory Approvals: Decisions by regulatory bodies, such as the FDA, regarding drug approvals and marketing authorizations directly impact SEELQ's commercial prospects and stock price.

Clinical Trial Results: Outcomes of clinical trials for SEELQ's drug candidates play a crucial role in determining the efficacy and safety of their products, affecting investor confidence and stock valuation.